Lubinski J, Vrdoljak V J, Beaman K D, Kwak J Y, Beer A E, Gilman-Sachs A
Department of Microbiology and Immunology, University of Health Sciences/Chicago Medical School, IL 60064.
J Reprod Immunol. 1993 Jul;24(2):81-96. doi: 10.1016/0165-0378(93)90012-7.
This study was designed to identify and characterize the allo- and autoantibodies induced following successful paternal lymphocyte immunization to prevent recurrent spontaneous abortion. Firstly the titers of maternal anti-paternal antibodies in women with successful pregnancies as determined by the flow cytometry crossmatch (FCXM) were highly variable; however, in all cases, the initial pre-immunization titers were negative and the post-immunization titers were positive by the FCXM in successfully treated women. Secondly, the specificities of maternal alloantibodies to paternal HLA antigens (immunogen) were evaluated. No all predicted antibodies to mismatched paternal HLA antigens were found by microlymphocytotoxicity (MCX) assays and the specificities varied. Thirdly, antibodies in post- but not preimmunization sera reacted with two lymphoid cell lines, SupT1 and SB; in addition, the rise and fall of the titers of these sera with paternal cells seemed to be reflected with the cell lines by the FCXM. Fourthly, autoantibodies to activated lymphocytes were detected and seemed to correlate with successful immunization since women who had another abortion following immunotherapy lacked these autoantibodies. These findings suggest that the antibody response following successful immunotherapy is complex and needs to be studied further to understand the mechanism of this treatment.
本研究旨在识别和表征在成功进行父淋巴细胞免疫以预防复发性自然流产后诱导产生的同种抗体和自身抗体。首先,通过流式细胞术交叉配型(FCXM)测定,成功妊娠女性体内的母源性抗父体抗体滴度高度可变;然而,在所有病例中,成功治疗的女性在免疫前的初始滴度为阴性,而免疫后的滴度通过FCXM检测为阳性。其次,评估了母源性同种抗体对父源性HLA抗原(免疫原)的特异性。通过微量淋巴细胞毒性(MCX)试验未发现针对不匹配父源性HLA抗原的所有预测抗体,且特异性各不相同。第三,免疫后而非免疫前血清中的抗体与两种淋巴细胞系SupT1和SB发生反应;此外,这些血清与父细胞的抗体滴度的升高和降低似乎通过FCXM在细胞系中得到反映。第四,检测到针对活化淋巴细胞的自身抗体,且似乎与成功免疫相关,因为免疫治疗后再次流产的女性缺乏这些自身抗体。这些发现表明,成功免疫治疗后的抗体反应是复杂的,需要进一步研究以了解这种治疗的机制。